Zucero Therapeutics Ltd Overview
- Headquarters
- Au
- Website
- zucero.com.au
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2016
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Zucero Therapeutics Ltd
Zucero is an Australian-based biotechnology company focussed on the development of pixatimod, an immunotherapy for the treatment of cancer. Pixatimod successfully completed safety evaluation in a Phase 1a clinical trial. It is currently under investigation in a Phase 1b study in combination with Opdivo® (immune checkpoint inhibitor) for pancreatic cancer, and new investigations in colon cancer is now being planned.
Compare Similar Companies to Zucero Therapeutics Ltd
Inia Health / MindCheck
It Services And It Consulting
SYNthesis Research
Biotechnology Research
De Groot Technical Services
Chemical Manufacturing
Bioessence Consultancy Services
Biotechnology Research
Funky Fungus
Biotechnology Research
TargaGenix
Biotechnology Research
CRE RESPOND
Research Services
Catalyst Therapeutics
Biotechnology Research
GENOME ILLUSTRATION
Biotechnology Research
Liquid Biopsy
Biotechnology Research